logo

La Jolla Pharmaceutical Co (LJPC)



Trade LJPC now with
  Date
  Headline
5/10/2018 4:51:15 PM La Jolla Q1 Net Loss $50.5 Mln Or $2.22 Per Share
5/10/2018 4:46:35 PM La Jolla Closes $125 Mln Royalty Financing Agreement With HealthCare Royalty Partners
3/15/2018 8:04:26 AM La Jolla Pharmaceutical Prices Public Offering Of 3.40 Mln Shares At $29.50 Per Share
3/14/2018 4:02:07 PM La Jolla Pharmaceutical Company Announces $100 Mln Public Offering Of Common Stock
2/25/2018 9:31:43 AM La Jolla Pharma: GIAPREZA Significantly Improved Survival Of Patients With High APACHE II Scores In ATHOS-3 Study
2/21/2018 9:01:57 AM La Jolla Pharma Announces Treatment Of First Patient In GIAPREZA Pediatric Study
2/12/2018 6:33:27 AM Jefferies Is Cutting La Jolla Pharmaceutical Co (LJPC) FY19 Rev. Estimate To 44.3 M From 54.1 M
2/12/2018 6:33:09 AM Jefferies Is Cutting La Jolla Pharmaceutical Co (LJPC) FY18 Rev. Estimate To 6.7 M From 52.9 M
2/12/2018 6:32:33 AM Jefferies Is Lowering La Jolla Pharmaceutical Co (LJPC) FY19 Estimate To -2.92 From -2.44
2/12/2018 6:32:13 AM Jefferies Is Lowering La Jolla Pharmaceutical Co (LJPC) FY18 Estimate To -4.28 From -2.38
2/12/2018 6:31:08 AM Jefferies Lowers La Jolla Pharmaceutical Co (LJPC) To Underperform From Buy With $29 Down From $40 Price Target
1/7/2018 9:50:22 AM New Drugs Approved In December
9/25/2017 6:35:50 AM La Jolla Pharma Announces Intent To Submit Marketing Authorization Application For LJPC-501 In Q3